Overview

BGI Asia-Pacific team was founded in the end of 2012. As an international team covering the Asia-Pacific region, we provide sequencing-based genetic services to almost one half of the world’s population and make great contributions to the globalization of BGI.

As a part of the world’s largest genomics institute specializing in genomics research and clinical applications, BGI Asia is engaged in providing genomics, bioinformatics and other Next-Generation sequencing based clinical services to the public. At present, our genetic services offer various tests for reproductive health (Non-invasive Trisomy Test, PGD/PGS, etc), newborn screening (Hearing Impairment, Autism, Metabolic Disorders, etc), cancer (Breast/Ovarian Cancer, Colorectal Cancer, etc), pathogenic microorganisms (HPV, HCV, HBV, etc), HLA typing , pharmacogenomics and more.

Life-cycle solutions is another service BGI Asia provides, it cover a variety of areas including both human-related research and clinical applications. Until now, we already built up stable relationship with many medical institutions, top hospitals, third-party agencies and biotech companies. Relying on the academic strength and professional clients-oriented attitude, BGI-health has gained excellent reputation worldwide.

With the state-of-the-art sequencing equipment, technology and knowhow in genomic research, BGI Asia focuses on developing genomics/bioinformatics methodologies and technologies, and offering clinical and genomics services to the Asia-Pacific region. Our mission is to make the genetic tests available, accessible and affordable to the general population with global collaborations, thus reduce the incidence of birth defects and eradicate certain human diseases.

BGI Health Asia-Pacific team is currently divided into four sections in charge of four different parts of the Asia-Pacific region, respectively. 

Southeast Asia

The Southeast Asia team of BGI Asia covers a series of regions including Singapore, Malaysia, Thailand, Vietnam, Indonesia, Philippines, etc. Teaming up with leading universities/institutes and top hospitals in the Southeast Asia region, we provid cutting-edge clinical genetic tests and medical research collaboration/services.

South Asia:

South Asia team covers India, Bangladesh, Pakistan, Sri Lanka, etc. Relying on the advanced technologies on genetic testing and strong research background of BGI, the team provides latest clinical services to countries in South Asia region. Up to now, South Asia team has already built up partnership with many leading medical institutions and biotech companies, thus gained great reputations in clinical excellence.

Middle East:

The Middle East is a region composed of southern and eastern Mediterranean countries, covering an area from eastern Mediterranean to the Persian Gulf. Through the hard work of the team, BGI Health had already set up collaborations in Saudi Arabia, the United Arab Emirates, Qatar, Kuwait, Oman, Jordan, Iraq and other countries. So far, thousands of pregnant women from Middle East have benefited from BGI’s NIFTY service, screening for chromosomal aneuploidy starting from the 10th week of pregnancy. Meanwhile, BGI also focuses on the screening and diagnosis of monogenic diseases, cancer, autism and other genetic tests.

Oceania:

Oceania region includes Australia and New Zealand, two highly developed countries with advanced economic, scientific and medical standards. Based on the state-of-the-art technology, BGI Asia provides NIFTY service and other genetic testing to the region with high quality and reliability. BGI Asia has established stable relationship with many local hospitals.

Hong Kong:

In July 2010, BGI HongKong was officially established. With over 100 units of high throughput sequencers, it has the highest sequencing capacity in the world.

For more information, please click BGI HK.

Japan:

BGI Japan was founded at the end of the year 2010 with its headquarter in Kobe.It is another business region after BGI Americas, BGI Europe and BGI Asia pacific.BGI Japan provides quality-ensured services with short turnaround time.

For more information, please click BGI Japan.

Laos:

BGI Laos was founded in 2007 with mission of supporting the national "going out" strategy and exploring innovative development modes, BGI Laos propose to combine the natural resources of Laos and BGI’s leading biotechnology to develop cooperations in Agriculture, Healthcare and other possible fields, together with Lao partners to advancing bioindustry development of Laos.

For more information, please click BGI Laos

Events


May, 2013
BGI Health signed cooperation agreement with S.R.L, the largest medical testing organization in India, to introduce the NIFTY test, cancer genetic tests and other genetic tests to India.
April, 2013
BGI Health Asia-Pacific team participated in the 2013 Human Genome Meeting and 21st International Congress of Genetics. Prof. Qi Ming and Dr. Zhang Lei gave excellent speeches on genomic research and clinical services in BGI. The meeting greatly enhanced BGI’s reputation in Southeast Asia and laid foundation for BGI’s local development.
April 2013
Dr. T. P. Baskaran accepted the invitation to be an honorary professor of BGI Health. As a highly respected regional leader in fetal medicine, Dr. Baskaran is helping to build up a network between maternal fetal medicines professionals in Malaysia and BGI Health.

April 11th, 2013
The delegates from Chulalongkorn Hospital, one of the top public hospitals in Thailand, visited BGI in Shenzhen. Prof. Dhiraphongs and Dr. Saknan discussed with BGI Health team about the collaboration on Newborn screening and other genetic diagnosis, together with the development of genomic applications in clinical medicine.
April, 2013
DNA Laboratories from Malaysia visited BGI in Shenzhen. CEO Dr. WONG Yongwee and Marketing Director Mr. Calvin Thien had a discussion on the collaboration details in reproductive and fetal health, as well as other clinical services.
April, 2013
BGI Health signed cooperation agreement to work with IVIOMICS from Spain in India, to promote the development and application of NIFTY service in north India, especially IVF hospitals.
March, 2013
BGI Health signed cooperation agreement with Srushti Hospital, one of the most famous Institute in India for reproductive medicine, to promote the development and application of NIFTY in south India, especially IVF hospitals.
March, 2013
BGI Health signed cooperation agreement with Metropolis, one of the biggest third-party clinical testing providers in India, aimed to introduce advanced genetic testing technology into India, to improve the reproductive health level of local residents.
March, 2013
The Eastern Biotech & Life Science in UAE co-organized with BGI Health for the launch seminar of NIFTY service in Dubai, and over a hundred local OB/GYN doctors participated. Dr. Ying LIU, the Marketing Director of BGI Asia-Pacific team, presented to the participants a variety of genetic tests provided by BGI, especially NIFTY. BGI Asia intends to reduce the incidence of birth defects and other genetic diseases in Middle East by introducing the most advanced genetic tests in local population. Genome web news link:http://www.genomeweb.com//node/1207906?hq_e=el&hq_m=1539296&hq_l=1&hq_v=ff9fa2f28c
March 4th, 2013
The delegates from Siriraj Hospital visited BGI. Siriraj Hospital is the largest public hospital in Thailand and the delegates signed a MOU with BGI on providing high quality medical services in Thailand.

February, 2013
INEX signed a strategic cooperation agreement with Primary Healthcare Limited, starting to promote BGI’s NIFTY services in seven states, especially major cities including Sydney, Melbourne, Brisbane, Adelaide, and Perth. Primary Health Care is one of the top medical companies in Australia, with 87 medical centers, 87 pathology laboratories and 782 sample collection centers. Through Laverty Pathology in Sydney, Dorevitch Pathology in Melbourne, QML pathology in Brisbane and Western Diagnostic in Perth, Primary Health Care is providing NIFTY service in Australia as iGeneScreen.
February, 2013
BGI Health was invited to exhibit and present sequencing-based genetic tests at the Jordan National Obstetrics and Gynecology Conference.


January, 2013
BGI Health Asia-Pacific team was invited to the International Conference on Next Evolution in Genetics and Genomics in New Delhi. Dr. Ying LIU, senior scientist and marketing director, gave an enlightening speech on NIFTY test.
October, 2012
Dr. Faruq, CEO of UAE Eastern Biotech & Life Science visited BGI, and reached a strategic cooperation agreement with BGI on genetic testing of monogenic diseases, thalassemia and hereditary tumors. 
September, 2012
BGI COO Mr. Yin Ye signed a cooperation agreement with INEX INNOVATIONS EXCHANGE in Singapore, aiming to promote women’s reproductive health in Southeast Asia. The non-executive director, Professor Mahesh Choolani is the top OB/GYN specialist in Singapore and the whole AP region and also an honorary professor of BGI.
September, 2012
BGI Health participated in India ISPAT Annual Meeting, and gave two presentations on our progress of NIFTY and Monogenic Diseases. The participation of BGI Health had greatly enhanced BGI’s image and laid foundation for local collaborations.

August, 2012
Rak Luke Maganize in Thailand reported the launch of NIFTY test in Thailand.
July, 2012
The first third-party testing laboratory in Thailand, Bangkok R.I.A LAB.C0.,LTD. (Bria lab), signed contract with BGI for NIFTY distribution in Thailand.
June, 2012
 BGI signed contract with Malaysia Fetal Genome Sdn Bhd, to promote NIFTY service in Malaysia.
June, 2012
Dr. Ying LIU, the Marketing Director of Asia-Pacific team, and Miss Shanshan Tang, the Sales Director, were invited to visit Erbil, Iraq and signed cooperation agreement with the Excellent Company in Iraq, aiming to introduce the most advanced genetic technology to Iraq.

April, 2012
BGI Diagnosis Asia-Pacific team participated in the 2012 Vietnam maternity medical congress. BGI Sales Director, Ms. Shanshan Tang, gave an inspiring speech on prenatal genetic testing.
March 9th2012
The delegates from the National Hospital for Obstetrics and Gynecology in Vietnam visited BGI.


February, 2012
BGI signed cooperation agreement with INEX (Inex Innovations Exchange), one of the top diagnostic products providers on gynecological health in Singapore. BGI authorizes INEX to promote NIFTY service in Australia, aiming to reduce the incidence of birth defects in Australia with the most reliable, secure and accurate genetic testing services.




















































































































































































Collaboration Highlights

Southeast Asia 

 Singapore

        INEX INNOVATIONS EXCHANGE PTE LTD   http://www.inex.sg

Malaysia

         DNA Laboratories Sdn Bhd    http://dna-laboratories.com

         Fetal Genome Sdn Bhd        

Thailand

         Bangkok BRIA Group   http://www.brianet.com

South Asia

Delhi

Sir Ganga Ram Hospital  www.sgrh.com 

IVIOMICS India  www.novaivifertility.com

Mumbai

S.R.L Diagnostics www.srldiagnostics.com/

Metropolis Healthcare Limited    www.metropolisindia.com

Chennai

Srusthi Fertility Centre  www.srushtiivf.com/


Middle East Asia

Sandi Arabia

Saudi Ajal for Health Services   http://saudiajal.net/

UAE

Eastern Biotech & Life Science   http://www.easternbiotech.com/

Scientific Clinical Laboratories   http://www.scluae.com/

Iraq

Excellent company 


Oceania

INEX                              www.igenescreen.com

Primary Health                 www.primaryhealthcare.com.au




BGI Asia-Pacific team was founded in the end of 2012. As an international team covering the Asia-Pacific region, we provide sequencing-based genetic services to almost one half of the world’s population and make great contributions to the globalization of BGI.

As a part of the world’s largest genomics institute specializing in genomics research and clinical applications, BGI Asia is engaged in providing genomics, bioinformatics and other Next-Generation sequencing based clinical services to the public. At present, our genetic services offer various tests for reproductive health (Non-invasive Trisomy Test, PGD/PGS, etc), newborn screening (Hearing Impairment, Autism, Metabolic Disorders, etc), cancer (Breast/Ovarian Cancer, Colorectal Cancer, etc), pathogenic microorganisms (HPV, HCV, HBV, etc), HLA typing , pharmacogenomics and more.

Life-cycle solutions is another service BGI Asia provides, it cover a variety of areas including both human-related research and clinical applications. Until now, we already built up stable relationship with many medical institutions, top hospitals, third-party agencies and biotech companies. Relying on the academic strength and professional clients-oriented attitude, BGI-health has gained excellent reputation worldwide.

With the state-of-the-art sequencing equipment, technology and knowhow in genomic research, BGI Asia focuses on developing genomics/bioinformatics methodologies and technologies, and offering clinical and genomics services to the Asia-Pacific region. Our mission is to make the genetic tests available, accessible and affordable to the general population with global collaborations, thus reduce the incidence of birth defects and eradicate certain human diseases.

BGI Health Asia-Pacific team is currently divided into four sections in charge of four different parts of the Asia-Pacific region, respectively. 

Southeast Asia

The Southeast Asia team of BGI Asia covers a series of regions including Singapore, Malaysia, Thailand, Vietnam, Indonesia, Philippines, etc. Teaming up with leading universities/institutes and top hospitals in the Southeast Asia region, we provid cutting-edge clinical genetic tests and medical research collaboration/services.

South Asia:

South Asia team covers India, Bangladesh, Pakistan, Sri Lanka, etc. Relying on the advanced technologies on genetic testing and strong research background of BGI, the team provides latest clinical services to countries in South Asia region. Up to now, South Asia team has already built up partnership with many leading medical institutions and biotech companies, thus gained great reputations in clinical excellence.

Middle East:

The Middle East is a region composed of southern and eastern Mediterranean countries, covering an area from eastern Mediterranean to the Persian Gulf. Through the hard work of the team, BGI Health had already set up collaborations in Saudi Arabia, the United Arab Emirates, Qatar, Kuwait, Oman, Jordan, Iraq and other countries. So far, thousands of pregnant women from Middle East have benefited from BGI’s NIFTY service, screening for chromosomal aneuploidy starting from the 10th week of pregnancy. Meanwhile, BGI also focuses on the screening and diagnosis of monogenic diseases, cancer, autism and other genetic tests.

Oceania:

Oceania region includes Australia and New Zealand, two highly developed countries with advanced economic, scientific and medical standards. Based on the state-of-the-art technology, BGI Asia provides NIFTY service and other genetic testing to the region with high quality and reliability. BGI Asia has established stable relationship with many local hospitals.

Hong Kong:

In July 2010, BGI HongKong was officially established. With over 100 units of high throughput sequencers, it has the highest sequencing capacity in the world.

For more information, please click BGI HK.

Japan:

BGI Japan was founded at the end of the year 2010 with its headquarter in Kobe.It is another business region after BGI Americas, BGI Europe and BGI Asia pacific.BGI Japan provides quality-ensured services with short turnaround time.

For more information, please click BGI Japan.

Laos:

BGI Laos was founded in 2007 with mission of supporting the national "going out" strategy and exploring innovative development modes, BGI Laos propose to combine the natural resources of Laos and BGI’s leading biotechnology to develop cooperations in Agriculture, Healthcare and other possible fields, together with Lao partners to advancing bioindustry development of Laos.

For more information, please click BGI Laos

May, 2013
BGI Health signed cooperation agreement with S.R.L, the largest medical testing organization in India, to introduce the NIFTY test, cancer genetic tests and other genetic tests to India.
April, 2013
BGI Health Asia-Pacific team participated in the 2013 Human Genome Meeting and 21st International Congress of Genetics. Prof. Qi Ming and Dr. Zhang Lei gave excellent speeches on genomic research and clinical services in BGI. The meeting greatly enhanced BGI’s reputation in Southeast Asia and laid foundation for BGI’s local development.
April 2013
Dr. T. P. Baskaran accepted the invitation to be an honorary professor of BGI Health. As a highly respected regional leader in fetal medicine, Dr. Baskaran is helping to build up a network between maternal fetal medicines professionals in Malaysia and BGI Health.

April 11th, 2013
The delegates from Chulalongkorn Hospital, one of the top public hospitals in Thailand, visited BGI in Shenzhen. Prof. Dhiraphongs and Dr. Saknan discussed with BGI Health team about the collaboration on Newborn screening and other genetic diagnosis, together with the development of genomic applications in clinical medicine.
April, 2013
DNA Laboratories from Malaysia visited BGI in Shenzhen. CEO Dr. WONG Yongwee and Marketing Director Mr. Calvin Thien had a discussion on the collaboration details in reproductive and fetal health, as well as other clinical services.
April, 2013
BGI Health signed cooperation agreement to work with IVIOMICS from Spain in India, to promote the development and application of NIFTY service in north India, especially IVF hospitals.
March, 2013
BGI Health signed cooperation agreement with Srushti Hospital, one of the most famous Institute in India for reproductive medicine, to promote the development and application of NIFTY in south India, especially IVF hospitals.
March, 2013
BGI Health signed cooperation agreement with Metropolis, one of the biggest third-party clinical testing providers in India, aimed to introduce advanced genetic testing technology into India, to improve the reproductive health level of local residents.
March, 2013
The Eastern Biotech & Life Science in UAE co-organized with BGI Health for the launch seminar of NIFTY service in Dubai, and over a hundred local OB/GYN doctors participated. Dr. Ying LIU, the Marketing Director of BGI Asia-Pacific team, presented to the participants a variety of genetic tests provided by BGI, especially NIFTY. BGI Asia intends to reduce the incidence of birth defects and other genetic diseases in Middle East by introducing the most advanced genetic tests in local population. Genome web news link:http://www.genomeweb.com//node/1207906?hq_e=el&hq_m=1539296&hq_l=1&hq_v=ff9fa2f28c
March 4th, 2013
The delegates from Siriraj Hospital visited BGI. Siriraj Hospital is the largest public hospital in Thailand and the delegates signed a MOU with BGI on providing high quality medical services in Thailand.

February, 2013
INEX signed a strategic cooperation agreement with Primary Healthcare Limited, starting to promote BGI’s NIFTY services in seven states, especially major cities including Sydney, Melbourne, Brisbane, Adelaide, and Perth. Primary Health Care is one of the top medical companies in Australia, with 87 medical centers, 87 pathology laboratories and 782 sample collection centers. Through Laverty Pathology in Sydney, Dorevitch Pathology in Melbourne, QML pathology in Brisbane and Western Diagnostic in Perth, Primary Health Care is providing NIFTY service in Australia as iGeneScreen.
February, 2013
BGI Health was invited to exhibit and present sequencing-based genetic tests at the Jordan National Obstetrics and Gynecology Conference.


January, 2013
BGI Health Asia-Pacific team was invited to the International Conference on Next Evolution in Genetics and Genomics in New Delhi. Dr. Ying LIU, senior scientist and marketing director, gave an enlightening speech on NIFTY test.
October, 2012
Dr. Faruq, CEO of UAE Eastern Biotech & Life Science visited BGI, and reached a strategic cooperation agreement with BGI on genetic testing of monogenic diseases, thalassemia and hereditary tumors. 
September, 2012
BGI COO Mr. Yin Ye signed a cooperation agreement with INEX INNOVATIONS EXCHANGE in Singapore, aiming to promote women’s reproductive health in Southeast Asia. The non-executive director, Professor Mahesh Choolani is the top OB/GYN specialist in Singapore and the whole AP region and also an honorary professor of BGI.
September, 2012
BGI Health participated in India ISPAT Annual Meeting, and gave two presentations on our progress of NIFTY and Monogenic Diseases. The participation of BGI Health had greatly enhanced BGI’s image and laid foundation for local collaborations.

August, 2012
Rak Luke Maganize in Thailand reported the launch of NIFTY test in Thailand.
July, 2012
The first third-party testing laboratory in Thailand, Bangkok R.I.A LAB.C0.,LTD. (Bria lab), signed contract with BGI for NIFTY distribution in Thailand.
June, 2012
 BGI signed contract with Malaysia Fetal Genome Sdn Bhd, to promote NIFTY service in Malaysia.
June, 2012
Dr. Ying LIU, the Marketing Director of Asia-Pacific team, and Miss Shanshan Tang, the Sales Director, were invited to visit Erbil, Iraq and signed cooperation agreement with the Excellent Company in Iraq, aiming to introduce the most advanced genetic technology to Iraq.

April, 2012
BGI Diagnosis Asia-Pacific team participated in the 2012 Vietnam maternity medical congress. BGI Sales Director, Ms. Shanshan Tang, gave an inspiring speech on prenatal genetic testing.
March 9th2012
The delegates from the National Hospital for Obstetrics and Gynecology in Vietnam visited BGI.


February, 2012
BGI signed cooperation agreement with INEX (Inex Innovations Exchange), one of the top diagnostic products providers on gynecological health in Singapore. BGI authorizes INEX to promote NIFTY service in Australia, aiming to reduce the incidence of birth defects in Australia with the most reliable, secure and accurate genetic testing services.

Southeast Asia 

 Singapore

INEX INNOVATIONS EXCHANGE PTE LTD   http://www.inex.sg

Malaysia

          Fetal Genome Sdn Bhd

         DNA Laboratories Sdn Bhd    http://dna-laboratories.com

         Quantum Diagnostics Sdn Bhd   http://www.quantumdxs.com

Thailand

         Bangkok BRIA Group   http://www.brianet.com

South Asia

Delhi

Sir Ganga Ram Hospital  www.sgrh.com 

IVIOMICS India  www.novaivifertility.com

Mumbai

S.R.L Diagnostics www.srldiagnostics.com/

Metropolis Healthcare Limited    www.metropolisindia.com

Chennai

Srusthi Fertility Centre  www.srushtiivf.com/


Middle East Asia

Sandi Arabia

Saudi Ajal for Health Services   http://saudiajal.net/

UAE

Eastern Biotech & Life Science   http://www.easternbiotech.com/

Scientific Clinical Laboratories   http://www.scluae.com/

Iraq

Excellent company 


Oceania

INEX                              www.igenescreen.com

Primary Health                 www.primaryhealthcare.com.au